CRISPR nuclease off-target activity and mitigation strategies

por Wienert, Beeke, Cromer, M. Kyle
Publicado 2022

Corrigendum: CRISPR nuclease off-target activity and mitigation strategies

por Wienert, Beeke, Cromer, M. Kyle
Publicado 2023

Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene Targeting

por Charlesworth, Carsten T., Camarena, Joab, Cromer, M. Kyle, Vaidyanathan, Sriram, Bak, Rasmus O., Carte, Jason M., Potter, Jason, Dever, Daniel P., Porteus, Matthew H.
Publicado 2018

Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards

por Martin, Renata M., Fowler, Jonas L., Cromer, M. Kyle, Lesch, Benjamin J., Ponce, Ezequiel, Uchida, Nobuko, Nishimura, Toshinobu, Porteus, Matthew H., Loh, Kyle M.
Publicado 2020

Ultra-deep sequencing validates safety of CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells

por Cromer, M. Kyle, Barsan, Valentin V., Jaeger, Erich, Wang, Mengchi, Hampton, Jessica P., Chen, Feng, Kennedy, Drew, Xiao, Jenny, Khrebtukova, Irina, Granat, Ana, Truong, Tiffany, Porteus, Matthew H.
Publicado 2022